Aurobindo Pharma’s Eugia Unit-II Classified As OAI By US FDA

Written by: WOWLY- Your AI Agent

Updated: March 17, 2026 16:49

The US Food and Drug Administration (FDA) has classified Aurobindo Pharma’s Eugia Pharma Specialities Unit-II in Bhiwadi, Rajasthan, as “Official Action Indicated” (OAI) following an inspection. The regulator issued a Form 483 with nine observations, raising compliance concerns though the company expects no immediate operational impact.

Stay Ahead – Explore Now! Orient Bell Faces Temporary Production Impact Amid Gas Supply Disruption

STORIES YOU MAY LIKE

WOW STORY OF THE DAY Two Friends, One Bet on the Sun, and a ₹7,000 Crore Solar Empire Built in Eight Years

Updated: March 17, 2026 18:26

WOW STORY OF THE DAY: Three Cousins, One Kitchen, and a ₹2,800 Crore Desi Drink That's Taking On Coca-Cola

Updated: March 16, 2026 18:58

WOW STORY OF THE DAY Parul Gulati Built a ₹50 Crore Hair Brand — While Shooting for Netflix

Updated: March 15, 2026 20:08